Research Priorities and Resource Allocation in the Investigation of New Drugs for Cancer in Least Developed Countries
Authors:
- Ricardo Eccard da SilvaRSRicardo Eccard da Silva
- Angélica Amorim AmatoAAAngélica Amorim Amato
- Débora Dornelas Belchior Costa AndradeDADébora Dornelas Belchior Costa Andrade
- Alessandra Vanessa Leite e SilvaASAlessandra Vanessa Leite e Silva
- Marta Rodrigues de CarvalhoMCMarta Rodrigues de Carvalho
- Maria Rita Carvalho Garbi NovaesMNMaria Rita Carvalho Garbi Novaes
Open Access
- 2 July 2018
- journal article
- review article
- Published by Wiley in Journal of Oncology
- Vol. 2018, 1-11
Abstract
Cancer incidence has increased significantly in low- and middle-income countries. The priorities of international health research are not always aligned with the global burden of cancer. This study aims to analyze global tendencies in clinical trials in oncology and discuss research priorities and resource allocation in the investigation of new drugs for cancers that significantly affect the least developed countries. This was a retrospective and analytical study that included data collected from the World Health Organization’s International Clinical Trials Registry Platform (ICTRP) in 2014. According to our results, there was a tendency for clinical trials involving breast and lung cancer to be conducted in countries with a lower level of economic development. On the other hand, cervical, stomach, and liver cancer, despite the significant burden that these place on middle- and low-income countries, were studied little among the countries selected. In conclusion, the organizations that most fund research to develop new drugs for cancer treatment continue to show little interest in prioritizing resources to fund research for certain types of cancer such as those of the cervix, stomach, and liver, which have a significant impact in low- and middle-income countries.Keywords
Funding Information
- Brazilian Health Regulatory Agency
- Universidade de Brasília
- Health Science Education and Research Foundation
This publication has 42 references indexed in Scilit:
- Cervical and female breast cancers in the Americas: current situation and opportunities for actionBulletin of the World Health Organization, 2013
- A comparison of cancer burden and research spending reveals discrepancies in the distribution of research fundingBMC Public Health, 2012
- The global cancer epidemic: opportunities for Canada in low- and middle-income countriesCanadian Medical Association Journal, 2012
- Cancer control in developing countries: using health data and health services research to measure and improve access, quality and efficiencyBMC International Health and Human Rights, 2010
- Expansion of cancer care and control in countries of low and middle income: a call to actionThe Lancet, 2010
- The Silent Epidemic of Exclusive University Licensing Policies on Compounds for Neglected Diseases and BeyondPLOS Neglected Tropical Diseases, 2010
- Ethical and Scientific Implications of the Globalization of Clinical ResearchNew England Journal of Medicine, 2009
- Payments to Normal Healthy Volunteers in Phase 1 Trials: Avoiding Undue Influence While Distributing Fairly the Burdens of Research ParticipationThe Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine, 2009
- Trends in the globalization of clinical trialsNature Reviews Drug Discovery, 2008
- Improving Access to Medicines in Poor Countries: The Role of UniversitiesPLOS Medicine, 2006